The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage

Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial

(2022) Trong Toan Nguyen et al.   LANCET

Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column

(2022) Sheng-Chieh Lien et al.   JOURNAL OF CHROMATOGRAPHY A

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies

(2021) Chih-Yeu Fang et al.   Expert Opinion on Drug Discovery

Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats

(2020) Kosuke Murakami et al.   VACCINE

Stability of Vaccines

(2019) N. Dumpa et al.   AAPS PHARMSCITECH

Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant

(2019) Hilde Vrieling et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine

(2019) Minna M. Hankaniemi et al.   VACCINE

Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures

(2018) Jessica A. White et al.   BIOLOGICALS

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease

(2018) Chih-Yeu Fang et al.   Expert Review of Vaccines

Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children

(2017) Kuan-Ying Arthur Huang et al.   Nature Communications

Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles

(2016) Chia-Chyi Liu et al.   ANTIVIRAL RESEARCH

Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years

(2015) Olivier Godeaux et al.   VACCINE

Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies

(2014) Ozan S. Kumru et al.   BIOLOGICALS

Review of Enterovirus 71 Vaccines

(2014) P. Chong et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems

(2014) Chih-Wei Lin et al.   Biomed Research International

Evaluation of the stability of enterovirus 71 virus-like particle

(2013) Shih-Yeh Lin et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2013) Feng-Cai Zhu et al.   LANCET

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

(2013) Aristine Cheng et al.   VACCINE

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates

(2012) Ai-Hsiang Chou et al.   PLoS One

Recent advances in the molecular epidemiology and control of human enterovirus 71 infection

(2012) Peter C McMinn   Current Opinion in Virology

Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

(2011) Chia-Chyi Liu et al.   JOURNAL OF VIROLOGICAL METHODS

Identification and characterization of a cross-neutralization epitope of Enterovirus 71

(2011) Chia-Chyi Liu et al.   VACCINE

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

(2011) Jui-Yuan Chang et al.   VACCINE

Virology, epidemiology, pathogenesis, and control of enterovirus 71

(2010) Tom Solomon et al.   LANCET INFECTIOUS DISEASES